QUADRANT CAPITAL GROUP LLC – Regeneron Pharmaceuticals, Inc. Transaction History
QUADRANT CAPITAL GROUP LLC portfolio value:
$540,000
portfolio value
QUADRANT CAPITAL GROUP LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +23.46% | 149 shares | 165K | $688.87 | 784 |
| Q2 2022 | share | Increase | +11.40% | 65 shares | -23K | $591.13 | 635 |
| Q1 2022 | share | Increase | +5.75% | 31 shares | 58K | $698.42 | 570 |
| Q4 2021 | share | Increase | +5.48% | 28 shares | 31K | $642.51 | 539 |
| Q3 2021 | share | Increase | +11.57% | 53 shares | 53K | $605.18 | 511 |
| Q2 2021 | share | Increase | +5.53% | 24 shares | 51K | $558.54 | 458 |
| Q1 2021 | share | Increase | +33.95% | 110 shares | 48K | $473.14 | 434 |
| Q4 2020 | share | Increase | +4.52% | 14 shares | -17K | $483.11 | 324 |
| Q3 2020 | share | Increase | +7.64% | 22 shares | -6K | $559.78 | 310 |
| Q2 2020 | share | Decrease | -58.38% | -404 shares | -153K | $623.65 | 288 |
| Q1 2020 | share | Increase | +160.15% | 426 shares | 238K | $488.29 | 692 |
| Q4 2019 | share | Increase | +817.24% | 237 shares | 88K | $375.48 | 266 |
| Q3 2019 | share | Decrease | -94.22% | -473 shares | -147K | $277.4 | 29 |
| Q2 2019 | share | Increase | +41.41% | 147 shares | 13K | $313 | 502 |
| Q1 2019 | share | Increase | +231.78% | 248 shares | 109K | $410.62 | 355 |
| Q4 2018 | share | Increase | +98.15% | 53 shares | 13K | $373.5 | 107 |
| Q3 2018 | share | Increase | +14.89% | 7 shares | 6K | $404.04 | 54 |
| Q2 2018 | share | Decrease | -35.62% | -26 shares | -10K | $344.99 | 47 |
| Q1 2018 | share | Decrease | -23.16% | -22 shares | -7K | $344.36 | 73 |
| Q4 2017 | share | Increase | +25.00% | 19 shares | -1K | $375.96 | 95 |
| Q3 2017 | share | Decrease | -13.64% | -12 shares | -7K | $447.12 | 76 |
| Q2 2017 | share | Increase | +120.00% | 48 shares | 26K | $491.14 | 88 |
| Q1 2017 | share | Decrease | -48.72% | -38 shares | -12K | $387.51 | 40 |
| Q4 2016 | share | Increase | +11.43% | 8 shares | -1K | $367.09 | 78 |
| Q3 2016 | share | Increase | +29.63% | 16 shares | 8K | $402.02 | 70 |
| Q2 2016 | share | Decrease | -57.48% | -73 shares | -24K | $349.23 | 54 |
| Q1 2016 | share | Increase | +89.55% | 60 shares | 8K | $360.44 | 127 |